| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 186.75B | 189.88B | 197.82B | 184.84B | 160.06B | 153.72B |
| Gross Profit | 25.32B | 25.76B | 28.44B | 27.71B | 25.79B | 17.26B |
| EBITDA | 22.61B | 23.13B | 24.34B | 22.93B | 22.10B | 14.18B |
| Net Income | 5.23B | 6.08B | 8.08B | 6.79B | 7.11B | 1.49B |
Balance Sheet | ||||||
| Total Assets | 193.98B | 197.76B | 191.74B | 178.40B | 172.62B | 152.61B |
| Cash, Cash Equivalents and Short-Term Investments | 22.73B | 26.27B | 28.72B | 22.34B | 21.57B | 17.15B |
| Total Debt | 8.26B | 10.07B | 7.75B | 9.37B | 13.94B | 10.05B |
| Total Liabilities | 70.52B | 70.28B | 71.29B | 67.31B | 69.39B | 57.01B |
| Stockholders Equity | 111.66B | 113.99B | 107.82B | 100.27B | 94.79B | 88.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -21.00M | 11.86B | 9.69B | 4.93B | -2.61B |
| Operating Cash Flow | 0.00 | 18.61B | 27.23B | 21.19B | 15.39B | 7.10B |
| Investing Cash Flow | 0.00 | -17.71B | -14.13B | -9.78B | -10.48B | -9.89B |
| Financing Cash Flow | 0.00 | -4.35B | -7.02B | -10.84B | -594.00M | -1.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥78.94B | 7.82 | ― | 4.95% | -5.89% | 8.95% | |
80 Outperform | ¥77.98B | 10.30 | ― | 3.85% | -4.47% | 29.68% | |
79 Outperform | ¥75.98B | 7.83 | 5.20% | 3.67% | -3.78% | -16.61% | |
76 Outperform | ¥71.48B | 7.00 | 11.87% | 5.00% | -10.87% | 153.16% | |
71 Outperform | ¥69.14B | 3.21 | ― | 3.66% | -6.79% | 303.74% | |
65 Neutral | ¥40.48B | 14.81 | 5.33% | 2.09% | 1.26% | 56.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |